SF Stifel Financial Corp.

Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader

Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader

ST. LOUIS, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the hiring of Brad Edgar as Managing Director and Lead Healthcare Equity Trader. He is based in the firm’s New York office and reports directly to R.J. Grant, Head of Global Equity Trading at Stifel.

Mr. Edgar joins Stifel from Seven Grand Managers, where he served as Partner, responsible for all risk execution and trading of the firm’s equity portfolio. He brings more than 20 years of healthcare equity trading experience to his new role, having held the position of Head of Healthcare Equity Trading at firms including BMO, Evercore, and UBS. He began his career in healthcare equity trading at Merrill Lynch.

“Brad brings over two decades of experience, successfully leading trading teams and cultivating strong relationships across the healthcare investment community, and we’re thrilled to welcome him to the team,” said R.J. Grant. “Healthcare is one of our most important verticals and this appointment underscores our commitment to attract outstanding talent and offer best in class execution services.”

Mr. Edgar added, “I am pleased to join Stifel, which continues to set the standard for premier client service and has significant momentum across the sector. I look forward to leveraging my industry experience and customer-centric approach to help drive best execution and extend our leadership position in healthcare.”

Stifel’s presence in the healthcare sector includes a dedicated specialist sales force, investment banking and equity research across all verticals of healthcare, and a flagship annual Healthcare Conference, which attracts 1,000 industry participants. Market making in more than 700 stocks across the healthcare spectrum, Stifel ranks among the largest traders of public healthcare companies.

Stifel Company Information

Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Stifel Independent Advisors, LLC. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at For global disclosures, please visit /investor-relations/press-releases.

Media Contact:

Neil Shapiro, +1 (212) 271-3447

Alex Hamer, +1 (212) 847-6673



EN
18/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Stifel Financial Corp.

 PRESS RELEASE

Stifel Reports October 2024 Operating Data

Stifel Reports October 2024 Operating Data ST. LOUIS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for October 31, 2024 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “Total client assets and fee-based assets increased 22% and 28%, respectively, from the same period a year ago, as we benefitted from strong market app...

Stifel Financial Corp: 1 director

A director at Stifel Financial Corp sold 10,500 shares at 113.820USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

 PRESS RELEASE

Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equi...

Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader ST. LOUIS, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the hiring of Brad Edgar as Managing Director and Lead Healthcare Equity Trader. He is based in the firm’s New York office and reports directly to R.J. Grant, Head of Global Equity Trading at Stifel. Mr. Edgar joins Stifel from Seven Grand Managers, where he served as Partner, responsible for all risk execution and trading of the firm’s equity portfolio. He brings more than 20 years of healthcare equity trading expe...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Ride the Trend Higher Our outlook remains bullish following the S&P 500's multi-month base breakout above 5670, alongside constructive market dynamics which have significantly improved over the past week. In last week's Compass (11/5/24) titled "Buy the Pullback," we discussed how we were buyers, noting that "once past the election, starting as early as today (election day) or tomorrow (day after the election), we believe there will be a strong end-of-year rally that will extend into the early ...

 PRESS RELEASE

Stifel Declares Quarterly Common Stock Cash Dividend and Declares Pref...

Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend ST. LOUIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.42 per share, payable December 16, 2024, to shareholders of record at the close of business on December 2, 2024. The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), 6.125% Non...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch